Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine.
about
Herpes simplex virus type 2 vaccines: new ground for optimism?Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization.Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.TLR-based immune adjuvants.Imiquimod as a dermatological therapy.Resiquimod and other immune response modifiers as vaccine adjuvants.Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential.Cytokines in experimental herpes simplex virus infection.The imidazoquinolines and their place in the therapy of cutaneous disease.Differential adjuvant activities of TLR7 and TLR9 agonists inversely correlate with nitric oxide and PGE2 productionTherapeutic use of Aldara in chronic myeloid leukemia.An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.Sensing herpes: more than toll.Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry.
P2860
Q33711912-637B2F1B-1BA0-472D-9B55-8FBE0A0EE570Q34123950-2481BD65-65E8-46BB-9000-9B8545F5F5C1Q34354995-203BEE02-6694-4CB9-B908-A523375337C3Q34400322-6D8D7821-D3F5-438B-9652-1645AD9E0416Q34546035-36FE2F7B-0207-4A5C-A166-C1511860F12AQ34700325-CC9B21A2-CBE7-4DA5-9744-5BB2140A68B3Q35015851-DEF17DE9-243D-4713-97BC-AD43E5D06326Q35027524-F9259140-CCCA-4835-AAB5-3A615654B929Q35164704-09405D48-D1A4-49F3-9DBE-9496495C1F50Q35392417-E79B36C1-7AD3-4F5E-AF5E-9A7D7B52CAE2Q36718548-F4EEC5AD-EC72-435E-A284-DA43FCCE460DQ36759693-5A462302-DF89-4482-959B-A6EC302DC376Q37948677-AEF14020-1FB8-412F-9E0C-355F1486291FQ44051922-21CA334B-0DD8-400E-A23A-EBE8CC539EBE
P2860
Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Reduction of recurrent HSV dis ...... d with a glycoprotein vaccine.
@ast
Reduction of recurrent HSV dis ...... d with a glycoprotein vaccine.
@en
type
label
Reduction of recurrent HSV dis ...... d with a glycoprotein vaccine.
@ast
Reduction of recurrent HSV dis ...... d with a glycoprotein vaccine.
@en
prefLabel
Reduction of recurrent HSV dis ...... d with a glycoprotein vaccine.
@ast
Reduction of recurrent HSV dis ...... d with a glycoprotein vaccine.
@en
P2093
P1433
P1476
Reduction of recurrent HSV dis ...... d with a glycoprotein vaccine.
@en
P2093
C J Harrison
D I Bernstein
R L Miller
P304
P356
10.1016/S0264-410X(00)00387-X
P407
P577
2001-02-01T00:00:00Z